Background Glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) are a class of medications initially developed to treat type 2 diabetes (T2D) and obesity
If youre dealing with conditions like hypothyroidism, PCOS, or Cushings syndrome, our medical team can create a personalized treatment plan to help manage these conditions alongside your Semaglutide GLP-1 treatment
Post hoc analysis of LEADER data revealed a persistent increase in the overall risk of biliary tract-related events and gallbladder diseases, consistently observed across four categories: uncomplicated gallbladder stones, complicated gallbladder stones, cholecystitis with/without gallbladder stones, and biliary obstruction [34]
Use of supplement oxygen is not prohibited
Several comments describe clinician follow-up messages appearing only after intake submission, rather than before enrollment